State Street’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $153K | Hold |
20,284
| – | – | ﹤0.01% | 3891 |
|
|
2026
Q1 | $138K | Hold |
20,284
| – | – | ﹤0.01% | 3971 |
|
|
2025
Q4 | $178K | Hold |
20,284
| – | – | ﹤0.01% | 3921 |
|
|
2025
Q3 | $248K | Buy |
20,284
+6,565
| +48% | +$61.7K | ﹤0.01% | 3846 |
|
|
2025
Q2 | $72.7K | Sell |
13,719
-3
| -0% | -$22 | ﹤0.01% | 4030 |
|
|
2025
Q1 | $106K | Hold |
13,722
| – | – | ﹤0.01% | 3964 |
|
|
2024
Q4 | $182K | Buy |
13,722
+35
| +0.3% | +$325 | ﹤0.01% | 3872 |
|
|
2024
Q3 | $137K | Sell |
13,687
-1,908
| -12% | -$28.8K | ﹤0.01% | 3914 |
|
|
2024
Q2 | $348K | Sell |
15,595
-70,920
| -82% | -$2.19M | ﹤0.01% | 3651 |
|
|
2024
Q1 | $5.08M | Buy |
86,515
+14,088
| +19% | +$607K | ﹤0.01% | 2918 |
|
|
2023
Q4 | $1.6M | Buy |
72,427
+4,192
| +6% | +$63.2K | ﹤0.01% | 3371 |
|
|
2023
Q3 | $1.47M | Sell |
68,235
-132,333
| -66% | -$5.2M | ﹤0.01% | 3434 |
|
|
2023
Q2 | $13.5M | Buy |
200,568
+37,521
| +23% | +$15.5M | ﹤0.01% | 2478 |
|
|
2023
Q1 | $76.1M | Sell |
163,047
-7,552
| -4% | -$4M | ﹤0.01% | 1370 |
|
|
2022
Q4 | $68.3M | Buy |
170,599
+1,621
| +1% | +$621K | ﹤0.01% | 1424 |
|
|
2022
Q3 | $55M | Sell |
168,978
-15,347
| -8% | -$4.94M | ﹤0.01% | 1529 |
|
|
2022
Q2 | $48.7M | Sell |
184,325
-12,786
| -6% | -$3.27M | ﹤0.01% | 1657 |
|
|
2022
Q1 | $59.2M | Buy |
197,111
+16,833
| +9% | +$5.87M | ﹤0.01% | 1650 |
|
|
2021
Q4 | $63.5M | Sell |
180,278
-80,245
| -31% | -$25M | ﹤0.01% | 1648 |
|
|
2021
Q3 | $66.6M | Buy |
260,523
+123,674
| +90% | +$43.8M | ﹤0.01% | 1594 |
|
|
2021
Q2 | $91.1M | Buy |
136,849
+16,009
| +13% | +$9.22M | ﹤0.01% | 1366 |
|
|
2021
Q1 | $105M | Sell |
120,840
-6,506
| -5% | -$6.93M | 0.01% | 1198 |
|
|
2020
Q4 | $118M | Buy |
127,346
+15,222
| +14% | +$16M | 0.01% | 1022 |
|
|
2020
Q3 | $115M | Sell |
112,124
-12,238
| -10% | -$13.2M | 0.01% | 892 |
|
|
2020
Q2 | $126M | Buy |
124,362
+17,880
| +17% | +$16.6M | 0.01% | 829 |
|
|
2020
Q1 | $92.5M | Buy |
106,482
+998
| +0.9% | +$992K | 0.01% | 899 |
|
|
2019
Q4 | $113M | Sell |
105,484
-8,627
| -8% | -$8.81M | 0.01% | 973 |
|
|
2019
Q3 | $105M | Sell |
114,111
-7,338
| -6% | -$8.06M | 0.01% | 974 |
|
|
2019
Q2 | $137M | Buy |
121,449
+11,433
| +10% | +$12.5M | 0.01% | 853 |
|
|
2019
Q1 | $149M | Buy |
110,016
+3,570
| +3% | +$4.84M | 0.01% | 780 |
|
|
2018
Q4 | $123M | Buy |
106,446
+1,942
| +2% | +$2.18M | 0.01% | 801 |
|
|
2018
Q3 | $159M | Buy |
104,504
+5,503
| +6% | +$8.48M | 0.01% | 805 |
|
|
2018
Q2 | $155M | Sell |
99,001
-9,848
| -9% | -$12.8M | 0.01% | 793 |
|
|
2018
Q1 | $126M | Buy |
108,849
+6,763
| +7% | +$8.91M | 0.01% | 881 |
|
|
2017
Q4 | $121M | Buy |
102,086
+25,897
| +34% | +$32.5M | 0.01% | 923 |
|
|
2017
Q3 | $102M | Buy |
76,189
+5,654
| +8% | +$5.96M | 0.01% | 969 |
|
|
2017
Q2 | $57M | Buy |
70,535
+9,956
| +16% | +$6.94M | 0.01% | 1285 |
|
|
2017
Q1 | $37.3M | Buy |
60,579
+6,033
| +11% | +$3.67M | ﹤0.01% | 1499 |
|
|
2016
Q4 | $29.2M | Buy |
54,546
+2,497
| +5% | +$1.25M | ﹤0.01% | 1618 |
|
|
2016
Q3 | $26.9M | Sell |
52,049
-1,113
| -2% | -$524K | ﹤0.01% | 1569 |
|
|
2016
Q2 | $21.8M | Sell |
53,162
-70
| -0.1% | -$32.1K | ﹤0.01% | 1694 |
|
|
2016
Q1 | $28.3M | Buy |
53,232
+6,974
| +15% | +$3.48M | ﹤0.01% | 1492 |
|
|
2015
Q4 | $35.2M | Buy |
46,258
+16,586
| +56% | +$11M | ﹤0.01% | 1358 |
|
|
2015
Q3 | $16.3M | Buy |
29,672
+4,036
| +16% | +$2.45M | ﹤0.01% | 1889 |
|
|
2015
Q2 | $15.1M | Buy |
25,636
+21,467
| +515% | +$12.5M | ﹤0.01% | 2028 |
|
|
2015
Q1 | $3.27M | Buy |
4,169
+1,159
| +39% | +$899K | ﹤0.01% | 2801 |
|
|
2014
Q4 | $2.06M | Buy |
+3,010
| New | +$1.94M | ﹤0.01% | 3029 |
|
Other funds holding KYNB
AC
BC
State Street's KYNB Position: Q2 2026 in Review
State Street held its Kyntra Bio (KYNB) position steady in Q2 2026 at 20,284 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #3891.
State Street first reported a position in KYNB in Q4 2014 and has held it in 47 quarters since. The position peaked at $159M in Q3 2018. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.
- State Street held 20,284 shares of Kyntra Bio worth $153K as of Q2 2026.
- State Street left its Kyntra Bio share count unchanged in Q2 2026.
- Kyntra Bio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3891 holding.
- State Street first reported a position in Kyntra Bio in Q4 2014 and has held it in 47 quarters since.
- State Street's Kyntra Bio position peaked at $159M in Q3 2018.
- 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.